Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Sep 27;12:730320. doi: 10.3389/fimmu.2021.730320

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2021 Zhao, Zhang, Xu, Yang, Liang, Zhang, Zhang and Zhang

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Subgroup analyses of the association between ICI rechallenge and all-grade or high-grade irAE occurrence after ICI rechallenge. CI, confidence interval; ICIs, immune checkpoint inhibitors; irAEs, immune-related adverse events; NSCLC, non-small cell lung cancer; OR, odds ratio. High-grade was considered as grade ≥3. “Global” indicates that the cohort included multiple irAEs. “Multiple” indicates that the cohort included patients with different cancer types. *The OR was directly presented without pooling because only one study was available.